AlphaSense SuperAnalyst

Recent biopharma seed and Series A funding rounds (late 2026)

Ten seed and Series A rounds announced Aug–Nov 2026, Series A first, then seed, as in the original table.

Recent biopharma seed and Series A funding rounds
Recent biopharma seed and Series A funding rounds, late 2026
Company name Funding type Amount raised (USD) Post-money valuation (USD) Lead investor Announcement date Source
Solstice Oncology Series A $225,000,000.00 $848,622,873.00 RA Capital Management 2026-09-09
Reju Therapeutics Series A – $550,492,550.00 – 2026-10-21
Infinimmune Series A $75,000,000.00 $347,529,635.00 Playground Global, Regeneron Ventures 2026-08-11
Afana Biotechnology Series A $50,000,000.00 $283,376,129.00 Anhui High-tech Industry Investment, Gaozheng Chuangtou, Hefei Industrial Investment Guozheng Equity Investment, Shenzhen Guozhong Venture Capital Management 2026-11-06
Breye Therapeutics Series A $76,725,907.00 $281,324,242.00 Mission BioCapital, Novo Holdings 2026-09-29
RegCell Series A $44,000,000.00 $260,178,673.00 Playground Global 2026-09-15
Libo Biotech Series A $15,020,879.00 $153,526,544.00 Loyal Valley Capital, Sinovation Ventures 2026-10-30
Cloverleaf Bio Seed $33,000,000.00 $123,197,670.00 4BIO Capital 2026-09-08
K2 Therapeutics Seed $50,000,000.00 $184,856,339.00 MPM Capital 2026-08-11
BioStack Seed $9,500,000.00 $41,830,752.00 Afore Capital, DCVC, Emerson Collective, Peak XV Partners, Streamlined, SV Angel, Verdict Capital, Y Combinator 2026-10-22